<code id='3EEA125C9B'></code><style id='3EEA125C9B'></style>
    • <acronym id='3EEA125C9B'></acronym>
      <center id='3EEA125C9B'><center id='3EEA125C9B'><tfoot id='3EEA125C9B'></tfoot></center><abbr id='3EEA125C9B'><dir id='3EEA125C9B'><tfoot id='3EEA125C9B'></tfoot><noframes id='3EEA125C9B'>

    • <optgroup id='3EEA125C9B'><strike id='3EEA125C9B'><sup id='3EEA125C9B'></sup></strike><code id='3EEA125C9B'></code></optgroup>
        1. <b id='3EEA125C9B'><label id='3EEA125C9B'><select id='3EEA125C9B'><dt id='3EEA125C9B'><span id='3EEA125C9B'></span></dt></select></label></b><u id='3EEA125C9B'></u>
          <i id='3EEA125C9B'><strike id='3EEA125C9B'><tt id='3EEA125C9B'><pre id='3EEA125C9B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:275
          Dozens of figures stand in Oceania on a 3D map — coverage from STAT
          Adobe

          The two patients had both died young from heart problems. When researchers looked at their DNA, they spotted another commonality: The two shared a particular version of a gene that helps the heart beat. Perhaps, the researchers thought, the variant could explain their heart conditions.

          Genomic datasets indicated the variant was rare, meaning it could be the cause of a rare disease. While most other labs that had seen the variant weren’t sure what it meant, one indicated it was likely disease-causing.

          advertisement

          The researchers set out to find out for sure. And after surveying labs around the world, poring through papers, and digging through datasets, the team found that the variant was in fact a harmless spelling of the gene in question. What’s more — it turned out the variant was not so rare after all.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech
          Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

          ThisistheinauguraleditionofAdam’sBiotechScorecard,anewsubscriber-onlynewsletter.STAT+subscriberscans

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Why the world’s most expensive drug might be worth the price

          AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b